Andexanet Alfa: First Global Approval.
- Published in:
- Drugs, 2018, v. 78, n. 10, p. 1049, doi. 10.1007/s40265-018-0940-4
- By:
- Publication type:
- Article
Works matching IS 00126667 AND DT 2018 AND VI 78 AND IP 10
Results: 8
1
2
Anlotinib: First Global Approval.
- Published in:
- Drugs, 2018, v. 78, n. 10, p. 1057, doi. 10.1007/s40265-018-0939-x
- By:
- Publication type:
- Article
3
Empagliflozin: A Review in Type 2 Diabetes.
- Published in:
- Drugs, 2018, v. 78, n. 10, p. 1037, doi. 10.1007/s40265-018-0937-z
- By:
- Publication type:
- Article
4
Lisdexamfetamine Dimesylate: A Review in Paediatric ADHD.
- Published in:
- Drugs, 2018, v. 78, n. 10, p. 1025, doi. 10.1007/s40265-018-0936-0
- By:
- Publication type:
- Article
5
Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide: A Review in HIV-1 Infection.
- Published in:
- Drugs, 2018, v. 78, n. 10, p. 1013, doi. 10.1007/s40265-018-0934-2
- By:
- Publication type:
- Article
6
Postural Orthostatic Tachycardia Syndrome: Prevalence, Pathophysiology, and Management.
- Published in:
- Drugs, 2018, v. 78, n. 10, p. 983, doi. 10.1007/s40265-018-0931-5
- By:
- Publication type:
- Article
7
The Evolution of Lung Transplant Immunosuppression.
- Published in:
- Drugs, 2018, v. 78, n. 10, p. 965, doi. 10.1007/s40265-018-0930-6
- By:
- Publication type:
- Article
8
Current and Emerging Therapeutics for the Management of Endometriosis.
- Published in:
- Drugs, 2018, v. 78, n. 10, p. 995, doi. 10.1007/s40265-018-0928-0
- By:
- Publication type:
- Article